LIKE MANY OTHER PROVIDERS, NP TO-GO OFFERED THEIR PATIENTS COPYCAT VERSIONS OF THE SEMAGLUTIDE FROM COMPOUNDING PHARMACIES, BUT THAT HAS COME TO A HALT AFTER THE FDA DECLARED THERE WAS NO LONGER A ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

New Delhi: Despite Mounjaro being priced lower in the Indian market compared to developed countries, viable and affordable anti-obesity medicines for Indian patients may still be about a year ...

Compounded semaglutide and Ozempic are different products. While both may be used in people with type 2 diabetes, Ozempic is approved by the FDA, but compounded semaglutide is not. Compounded ...

Share on Pinterest Common antidiabetes drugs could help lower Alzheimer’s risk, increasing evidence suggests. Image credit: mbbirdy/Getty Images. A new study investigates the relationship ...

Semaglutide is an injectable medication available as Ozempic and Rybelsus to treat type 2 diabetes and Wegovy for managing overweight or obesity. GLP-1 is a hormone produced by the intestines.

While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire across the globe and make inroads into large markets like Brazil.

However, at the two-year, three-year, and four-year time points from the index date, those taking semaglutide had an increased risk for NAION (hazard ratios, 2.39, 2.44, and 2.05, respectively).

Using real-world data from over 300,000 cases, scientists uncovered a significant link between semaglutide and reported vision problems—raising new concerns about the safety profile of this ...

Semaglutide (the active ingredient in Ozempic and Wegovy) is commonly used to treat type 2 diabetes and obesity. © Starmarpro via Shutterstock The case for Ozempic ...

Semaglutide brand names include Ozempic, Rybelus, and Wegovy, all made by Novo Nordisk, and Mounjaro from Eli Lilly. The study, led by the Centers for Disease Control and Prevention and Cambridge ...

Semaglutide is one type of GLP-1RA drug approved in the UK for diabetes management (Ozempic) and weight loss (Wegovy)Credit: Alamy These were GLP-1 receptor agonists (GLP-1RAs), which include ...